Suppr超能文献

短链3-羟酰基辅酶A脱氢酶高胰岛素血症的遗传发病机制、诊断及治疗

Genetic pathogenesis, diagnosis, and treatment of short-chain 3-hydroxyacyl-coenzyme A dehydrogenase hyperinsulinism.

作者信息

Zhang Wei, Sang Yan-Mei

机构信息

Medizinische Klinik and Poliklinik IV, Klinikum der Universität München, LMU München, Munich, Germany.

Department of Pediatric Endocrinology, Genetic and Metabolism, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.

出版信息

Orphanet J Rare Dis. 2021 Nov 4;16(1):467. doi: 10.1186/s13023-021-02088-6.

Abstract

Congenital hyperinsulinism (CHI), a major cause of persistent and recurrent hypoglycemia in infancy and childhood. Numerous pathogenic genes have been associated with 14 known genetic subtypes of CHI. Adenosine triphosphate-sensitive potassium channel hyperinsulinism (KATP-HI) is the most common and most severe subtype, accounting for 40-50% of CHI cases. Short-chain 3-hydroxyacyl-coenzyme A dehydrogenase hyperinsulinism (SCHAD-HI) is a rare subtype that accounts for less than 1% of all CHI cases that are caused by homozygous mutations in the hydroxyacyl-coenzyme A dehydrogenase (HADH) gene. This review provided a systematic description of the genetic pathogenesis and current progress in the diagnosis and treatment of SCHAD-HI to improve our understanding of this disease.

摘要

先天性高胰岛素血症(CHI)是婴幼儿期持续性和复发性低血糖的主要原因。众多致病基因已与CHI的14种已知遗传亚型相关联。三磷酸腺苷敏感性钾通道高胰岛素血症(KATP-HI)是最常见且最严重的亚型,占CHI病例的40-50%。短链3-羟酰基辅酶A脱氢酶高胰岛素血症(SCHAD-HI)是一种罕见亚型,在所有由羟酰基辅酶A脱氢酶(HADH)基因纯合突变引起的CHI病例中占比不到1%。本综述对SCHAD-HI的遗传发病机制以及诊断和治疗的当前进展进行了系统描述,以增进我们对该疾病的了解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a08/8567654/e36cc941f4ae/13023_2021_2088_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验